FMC Corporation (FMC)
Materials · Agricultural Chemicals · NYSE
FMC Corporation is a global agricultural sciences company focused on providing innovative crop protection and plant health solutions to farmers.
What FMC Corporation does
FMC Corporation is an agricultural sciences company that provides solutions for crop protection, plant health, and professional pest and turf management. The company develops and markets a portfolio of innovative, science-based products including insecticides, herbicides, and fungicides.
Themes: crop protection, agriculture technology, sustainable farming, pest control
Fundamentals
- Price$8.92 as of 2026-10-08 close
- Market cap$1.1B as of 2026-06-30 (share count; price 2026-10-08)
- 1-year return-70.6% 2025-10-08 close $30.34 → 2026-10-08 close $8.92
- P/En/a negative earnings
- Net margin-64.6% FY2025, SEC XBRL
- Gross margin+37.0% FY2025, SEC XBRL
- ROE-106.7% FY2025, SEC XBRL
- Debt / equity2.62 as of 2026-09-03
- Revenue growth (YoY)-21.3% as of 2026-09-03
- Revenue CAGR (3y)-15.8% SEC XBRL
- Beta1.06 as of 2026-09-03
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +3.2%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How FMC compares in its sector
- net profit marginbottom 10% 125 covered Materials peers, as of 2026-09-03
- operating marginbottom 10% 108 covered Materials peers, as of 2026-09-03
- gross margintop 25% 92 covered Materials peers, as of 2026-09-03
- return on equitybottom 10% 144 covered Materials peers, as of 2026-09-03
- 3-year revenue CAGRbottom 10% 127 covered Materials peers
- indicated dividend yieldtop 25% 95 covered Materials peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)bottom 10% 122 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Not assessable from available data. FMC paid a dividend in FY2025, but coverage cannot be assessed from the available data (non_positive_net_income, non_positive_free_cash_flow).
- Earnings payoutnot assessable earnings were not positive that year
- Free-cash-flow payoutnot assessable free cash flow was not positive that year
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How FMC Corporation looks technically
FMC Corporation (FMC) is trading 32.2% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 455 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 28, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 5 trading days ago. It is 72.4% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 32.2% below its 200-day average, the long-term trend line — a long-term downtrend | -32.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $10.60 | $10.60 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $13.16 | $13.16 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 36 calendar days ago — the swings before that are what the structure reading is measured on | 36 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 455 trading days ago — a "death cross", a bearish long-term signal | 455 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 28, with sellers in control | 28.2 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30) | 36.0 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($8.33 to $10.76) — its "stochastic" reading is 24 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 24.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 19 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $32.34 | $32.34 |
|---|---|---|
| From the 52-week high | it is 72.4% below its 52-week high (its highest price of the past year) | -72.4% |
| Above the 52-week low | it is 7.1% above its 52-week low (its lowest price of the past year) | +7.1% |
| Below the 52-week high | it is 72.4% below its highest point of the past year | 72.4% |
| Since a 20-day breakout | it made a new 20-day low about 5 trading days ago | 5 sessions |
| Since a 55-day breakout | it made a new 55-day low about 5 trading days ago | 5 sessions |
| All-time high | its highest closing price on record is $140.99 (set on 2022-04-20) | $140.99 |
| Given back of the 52-week move | over the past year its closes ranged ($8.44 to $32.24), and it has recovered only a small part of its fall from last year’s high — 2% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $23.15 to $23.91. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 2.0% |
| From the all-time high | it is 93.7% below its all-time high | -93.7% |
| Nearest price level | it is trading 11.5% below a resistance level at $9.95 — a price it turned at twice since 2026-07-29, most recently on 2026-08-13. Since 2024-10-08 it has 0 such levels below the current price and 15 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +11.5% |
| All-time low | its lowest closing price on record is $8.33 (set on 2026-10-02) | $8.33 |
| Above the all-time low | it is 7.1% above its all-time low | +7.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 87% of the past ~6 months) | 87th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.5265 between its high and its low — about 5.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.5265 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.97 and $11.52 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.97 – $9.75 – $11.52 |
| Typical daily range (% of price) | its price moves about 5.9% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.9% |
| Stretch from the 200-day average | it is trading 8.1 daily ranges below its 200-day average price (32.2% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 8.1 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.00× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.6% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.6% |
|---|---|---|
| Gap filled | a 2.4% gap up opened on 2026-08-28 has been "filled" 16 sessions ago — price traded back through the level the gap left behind, and it took 12 sessions to close | 16 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 31.4 percentage points (the stock lost 30.4% while the market gained 1.0%) | -31.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 22.3 percentage points (the stock lost 18.5% while the market gained 3.8%) | -22.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 65.6 percentage points (the stock lost 48.2% while the market gained 17.5%) | -65.6% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 85.6 percentage points (the stock lost 70.6% while the market gained 15.0%) | -85.6% |
Signal agreement
2
| Bullish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bullish state — these describe past price behaviour, not a forecast | 0 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 20% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thin, spanning 0.3% of the share price, which is taken to mean a barrier that gives way easily. | -19.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 31% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $12.89 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | -30.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 15% below the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is under water. That average is $10.44 — a volume-weighted average of daily closes over 51 sessions, not a true tick-by-tick VWAP. | -14.5% |
Price levels it has turned at before
FMC last closed at $8.92 on 2026-10-08. Since 2024-10-08 it has turned at 0 prices below its last close and 15 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $9.95 | Resistance | 11.5% above the last close | turned there twice · 2026-07-29 to 2026-08-13 |
| $10.74 | Resistance | 20.4% above the last close | turned there three times · 2026-06-11 to 2026-07-01 |
| $12.21 | Resistance | 36.8% above the last close | turned there four times · 2025-11-20 to 2026-07-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · lagging the market · Stretched far below its 200-day average (6+ daily ranges) · Under water since its last earnings report (below the anchored VWAP) · Trading below the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.47 mean, 1=Strong Buy…5=Strong Sell) — 16 analysts
- Mean price target$13.26 range $10.00 – $21.00; median $12.00
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for FMC
- Consensus EPS estimate$0.106 next reporting period, as of 2026-10-09
- Estimate change, 30 days-$0.00441 (-4.0%) from $0.1104, on 2026-09-04, 35-day window
- Readings revised upward22% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High debt levels and potential liquidity challenges","Exposure to volatility in global agricultural markets and commodity pricing","Risks associated with product development, regulatory approvals, and environmental liabilities"]
What changed in the latest 10-Q
AI-assisted comparison of FMC's 10-Q filed 2026-07-30 against the prior one filed 2026-04-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-07-30) adds a new 'Strategic Review' subsection announcing that on June 30, 2026, FMC entered into a definitive agreement for Tessenderlo Group to make a strategic minority equity investment of approximately $400 million at $13.30 per share, resulting in Tessenderlo Group owning approximately 20.0% of FMC common stock.
- Newer filing (2026-07-30) states that the Tessenderlo transaction represents the conclusion of the FMC Board of Directors' exploration of strategic options announced in February 2026, and that FMC intends to use the funds to pay down debt.
- Newer filing (2026-07-30) adds a 'Second Quarter 2026 Highlights' subsection with financial highlights for the three months ended June 30, 2026 compared to June 30, 2025.
- Newer filing (2026-07-30) reports revenue of $867.1 million for the three months ended June 30, 2026, a decrease of $183.4 million (approximately 17 percent) versus the prior year period.
- Newer filing (2026-07-30) reports gross margin of $342.1 million, a decrease of $64.2 million versus the prior year quarter, with gross margin as a percent of revenue of approximately 39 percent flat compared to the prior year period.
- Newer filing (2026-07-30) reports selling, general and administrative expenses were $179.1 million, an increase of approximately 1 percent versus the prior year period, and research and development expenses of $60.4 million decreased $6.0 million (9 percent).
- Newer filing (2026-07-30) reports net loss attributable to FMC stockholders of $186.6 million, a decrease of $253.3 million from net income of $66.7 million in the prior year period, largely driven by an increase of $185.6 million in restructuring and other charges (income) primarily due to Project Foundation costs.
- Removed:
- Older filing (2026-04-30) contains an 'India Held for Sale Business' subsection that is removed in the newer filing.
- Older filing (2026-04-30) states that in July 2025, the Board of Directors approved a plan to divest the Company's commercial business in India, with the sale process expected to conclude during 2026.
- Older filing (2026-04-30) includes a table of India held for sale business adjustments for the three months ended March 31, 2026, showing operating results of $34.1 million, asset impairment of ($20.4) million, third party provider costs of $2.7 million, and total India held for sale business of $16.4 million.
- Older filing (2026-04-30) states that the carrying value of the India held for sale business decreased from $450 million as of December 31, 2025 to $425.0 million as of March 31, 2026, comprised of $445.4 million of net assets held for sale and a $20.4 million foreign currency translation gain.
- Older filing (2026-04-30) contains a 'First Quarter 2026 Highlights' subsection with financial highlights for the three months ended March 31, 2026 compared to March 31, 2025.
- Older filing (2026-04-30) reports revenue of $758.6 million for the three months ended March 31, 2026, a decrease of $32.8 million (approximately 4 percent) versus the prior year period.
- Reworded:
- The older filing's 'First Quarter 2026 Highlights' section is replaced by the newer filing's 'Second Quarter 2026 Highlights' section reflecting the change in reporting period from Q1 2026 (three months ended March 31, 2026) to Q2 2026 (three months ended June 30, 2026).
- Notes:
- The newer filing excerpt is truncated mid-sentence at the end of the provided text (ending with '...comprehensive plan to further optimize FMC's cost structure and organ'), so changes after that point cannot be assessed.
- The older filing excerpt is also truncated mid-sentence ('Volume improved du'), so the full Q1 2026 highlights content after that point is not available for comparison.
Risk Factors
- Added:
- Newer filing (2026-07-30) adds Exhibit 4.1: Indenture dated as of June 5, 2026 among the Company, the Subsidiary Guarantors, and U.S. Bank Trust Company as Trustee and Notes Collateral Agent.
- Newer filing (2026-07-30) adds Exhibit 4.2: Form of Global Note representing 8.000% Senior Secured Notes due 2031.
- Newer filing (2026-07-30) adds Exhibit 10.1: Real Estate Purchase and Sale Agreement between FMC Corporation and Encor Elkton, LLC.
- Newer filing (2026-07-30) adds Exhibit 10.2: Amendment No. 7 dated June 16, 2026 to Fifth Amended and Restated Credit Agreement.
- Newer filing (2026-07-30) adds Exhibit 10.3: Stock Purchase Agreement dated June 30, 2026 between FMC Corporation and Tessenderlo Group NV, with Investor Agreement and Registration Rights Agreement forms.
- Removed:
- Older filing (2026-04-30) included Exhibit 3.1: Certificate of Amendment to Restated Certificate of Incorporation effective April 29, 2026, which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 3.2: Amended and Restated By-Laws as of April 28, 2026, which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 10.1: Amendment No. 6 dated April 16, 2026 to the Fifth Amended and Restated Credit Agreement, which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 10.2: FMC Corporation 2026 Incentive Stock Plan, which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 10.2a: Form of Employee Performance-Based Stock Unit Award Agreement (Total Shareholder Return Metric), which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 10.2b: Form of Employee Performance-Based Stock Unit Award Agreement (Return on Invested Capital Metric), which is absent from the newer filing.
- Older filing (2026-04-30) included Exhibit 10.2c: Form of Employee Performance-Based Stock Unit Award Agreement (Return on Invested Capital Metric), which is absent from the newer filing.
- Reworded:
- Risk factors cross-reference: newer filing (2026-07-30) references 'our 2025 Form 10-K'; older filing (2026-04-30) references 'our Annual Report on Form 10-K for the year ended December 31, 2025 ("Form 10-K")'.
- Securities Trading Plans statement period: newer filing (2026-07-30) refers to 'During the three months ended June 30, 2026'; older filing (2026-04-30) refers to 'During the three months ended March 31, 2026'.
- Issuer Purchases table period: newer filing (2026-07-30) shows April, May, June 2026 data with Total Q2 2026 of 73,096 shares at $12.68; older filing (2026-04-30) shows January, February, March 2026 data with Total Q1 2026 of 62,359 shares at $14.66.
- Share repurchase program statement period: newer filing (2026-07-30) states 'during the six months ended June 30, 2026'; older filing (2026-04-30) states 'during the three months ended March 31, 2026'.
- Remaining repurchase program amount date: newer filing (2026-07-30) states 'At June 30, 2026, $825 million remained unused'; older filing (2026-04-30) states 'At March 31, 2026, $825 million remained unused'.
- Signatures date: newer filing (2026-07-30) is dated July 30, 2026; older filing (2026-04-30) is dated April 30, 2026.
- Notes:
- The section supplied by the user is labeled 'Risk Factors' but contains the full Part II of each 10-Q, including Items 2, 5, 6 and Signatures. Changes reported above cover the entire supplied text, not only Item 1A.
- The actual Item 1A Risk Factors text is identical between the two filings except for the cross-reference wording; no substantive risk factor changes appear in the supplied excerpts.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 1 sell ($15982) — 1 selling insider
- Last 180 days · read to 2026-10-040 buys · 1 sell ($15982) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-09. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about FMC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 5 matched disclosures for FMC from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding FMC as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 31,925,712
- Reported value $367,661,177
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about FMC's institutional holders → See what each manager we track holds →
Short interest (FINRA)
FMC had 26,746,756 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
FMC had 21.4% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 8.08 days to cover at the same settlement.
- Reported short interest (shares) 26,746,756
- Short interest (% of shares outstanding) 21.4%
- Prior settlement (shares) 29,561,922
- Reported change -9.52%
- Days to cover (reported) 8.08
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Bayer CropScience (BAYRY)
- Syngenta (owned by ChemChina)
- Corteva (CTVA)
- BASF Agricultural Solutions (BASFY)
- UPL Limited
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare FMC vs…
Frequently asked questions
What does FMC Corporation (FMC) do?
FMC Corporation is an agricultural sciences company that provides solutions for crop protection, plant health, and professional pest and turf management. The company develops and markets a portfolio of innovative, science-based products including insecticides, herbicides, and fungicides.
What sector is FMC Corporation (FMC) in?
FMC Corporation (FMC) is classified in the Materials sector. Its industry is Agricultural Chemicals. It trades on NYSE.
Does FMC pay a dividend?
Yes — FMC Corporation (FMC) pays a dividend, with an indicated yield of about 3.17% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are FMC Corporation's (FMC) competitors?
Notable peers of FMC Corporation (FMC) include Bayer CropScience, Syngenta (owned by ChemChina), Corteva, BASF Agricultural Solutions and UPL Limited. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in FMC?
Yes — we hold 5 matched STOCK Act disclosures for FMC from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is FMC Corporation (FMC) overbought or oversold right now?
FMC Corporation (FMC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 36, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on FMC come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.